• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国一家三级癌症中心卵巢癌膈肌手术围手术期并发症的管理

Management for perioperative complications of diaphragmatic surgery in ovarian cancer at a Chinese tertiary cancer center.

作者信息

Ha Xinyu, Feng Zheng, Wu Yangjun, Liu Ziqi, Ju Xingzhu, Wen Hao, Wu Xiaohua

机构信息

Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

J Gynecol Oncol. 2025 May;36(3):e109. doi: 10.3802/jgo.2025.36.e109. Epub 2025 Apr 10.

DOI:10.3802/jgo.2025.36.e109
PMID:40275686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12099035/
Abstract

OBJECTIVE

Diaphragm is the common site of metastasis in advanced ovarian cancer. Diaphragmatic surgery is necessary to achieve complete resection. Relative complications also pose challenges to perioperative management. This study aims to explore the influencing factors and management strategies for perioperative complications of diaphragm surgery.

METHODS

This study retrospectively included 396 patients who underwent diaphragmatic surgery for advanced ovarian cancer at Fudan University Shanghai Cancer Center from July 2015 to June 2022. Diaphragm surgical methods were classified, and perioperative complications were regarded according to Memorial Sloan Kettering Cancer Center criteria. Clinical characteristics and perioperative complications were analyzed to find correlations to establish the nomogram.

RESULTS

Among the 396 patients, 163 patients (41.2%) suffered from perioperative complications. Pleural effusion (33.1%) and pneumothorax (5.3%) were the most commonly reported. Patients with longer surgery duration (>3 hours) (p=0.003) and who underwent diaphragmatic incision surgery (p=0.004) had a higher incidence of postoperative complications. The incidence of postoperative pleural effusion was significantly higher in patients who underwent diaphragm full-thickness resection (49.3%) than diaphragmatic stripping (29.5%) (p=0.001), and patients who underwent diaphragm full-thickness resection are more likely to require drainage (p=0.001). Multi-variate analyses showed that stage IV tumor, long operation time, and diaphragm full-thickness resection are associated with postoperative pleural effusion.

CONCLUSION

Pleural effusion is the most common complication of diaphragmatic surgery in patients with ovarian cancer. Routine placement of prophylactic chest tubes is not appropriate for all patients undergoing diaphragmatic surgery. Our nomogram could help to predict its risk and indicate prophylactic management.

摘要

目的

膈肌是晚期卵巢癌常见的转移部位。膈肌手术对于实现完整切除是必要的。相关并发症也给围手术期管理带来挑战。本研究旨在探讨膈肌手术围手术期并发症的影响因素及管理策略。

方法

本研究回顾性纳入了2015年7月至2022年6月在复旦大学附属肿瘤医院接受晚期卵巢癌膈肌手术的396例患者。对膈肌手术方法进行分类,并根据纪念斯隆凯特琳癌症中心标准对围手术期并发症进行评估。分析临床特征与围手术期并发症之间的相关性以建立列线图。

结果

在396例患者中,163例(41.2%)发生围手术期并发症。最常见的是胸腔积液(33.1%)和气胸(5.3%)。手术时间较长(>3小时)(p=0.003)以及接受膈肌切开手术(p=0.004)的患者术后并发症发生率较高。接受膈肌全层切除术的患者术后胸腔积液发生率(49.3%)显著高于膈肌剥除术患者(29.5%)(p=0.001),且接受膈肌全层切除术的患者更有可能需要引流(p=0.001)。多因素分析显示,IV期肿瘤、手术时间长和膈肌全层切除术与术后胸腔积液相关。

结论

胸腔积液是卵巢癌患者膈肌手术最常见的并发症。常规放置预防性胸管并不适用于所有接受膈肌手术的患者。我们的列线图有助于预测其风险并指导预防性管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/12099035/84a5c2aff58f/jgo-36-e109-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/12099035/2a1836e935e0/jgo-36-e109-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/12099035/84a5c2aff58f/jgo-36-e109-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/12099035/2a1836e935e0/jgo-36-e109-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/12099035/84a5c2aff58f/jgo-36-e109-g002.jpg

相似文献

1
Management for perioperative complications of diaphragmatic surgery in ovarian cancer at a Chinese tertiary cancer center.中国一家三级癌症中心卵巢癌膈肌手术围手术期并发症的管理
J Gynecol Oncol. 2025 May;36(3):e109. doi: 10.3802/jgo.2025.36.e109. Epub 2025 Apr 10.
2
Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma.晚期卵巢癌、输卵管癌和腹膜癌初次肿瘤细胞减灭术中的膈肌手术及相关并发症
BMC Cancer. 2017 May 5;17(1):317. doi: 10.1186/s12885-017-3311-8.
3
Surgical outcomes of diaphragmatic resection during cytoreductive surgery for advanced gynecological ovarian neoplasia: A randomized single center clinical trial - DRAGON.在高级妇科卵巢肿瘤的细胞减灭术中进行膈肌切除术的手术结果:一项随机单中心临床试验 - DRAGON。
Gynecol Oncol. 2022 Feb;164(2):271-277. doi: 10.1016/j.ygyno.2021.11.012. Epub 2021 Nov 26.
4
Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer.晚期苗勒管癌行膈肌腹膜切除术或切除术后胸腔积液的发生率及处理
Gynecol Oncol. 2006 Dec;103(3):871-7. doi: 10.1016/j.ygyno.2006.05.023. Epub 2006 Jul 3.
5
Assessment of intraoperative tube thoracostomy after diaphragmatic resection as part of debulking surgery for primary advanced-stage Müllerian cancer.评估膈切除术术中胸腔引流管的应用,膈切除术是原发性晚期 Müllerian 癌廓清手术的一部分。
Gynecol Oncol. 2013 Oct;131(1):32-5. doi: 10.1016/j.ygyno.2013.07.091. Epub 2013 Jul 25.
6
Surgical procedures and morbidities of diaphragmatic surgery in patients undergoing initial or interval debulking surgery for advanced-stage ovarian cancer.初治或间隔减瘤术治疗晚期卵巢癌患者的膈肌手术的手术步骤和并发症。
J Am Coll Surg. 2010 Apr;210(4):509-14. doi: 10.1016/j.jamcollsurg.2010.01.011.
7
Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer.在 89 例 IIIB-IV 期上皮性卵巢癌患者的初次肿瘤细胞减灭术中进行膈肌手术。
Gynecol Oncol. 2010 Mar;116(3):489-96. doi: 10.1016/j.ygyno.2009.07.014. Epub 2009 Dec 1.
8
Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer.卵巢癌细胞减灭术中行膈肌全层切除及经膈肌行气胸减压的手术技术。
Gynecol Oncol. 2010 Nov;119(2):255-8. doi: 10.1016/j.ygyno.2010.07.017. Epub 2010 Aug 23.
9
Diaphragmatic Surgery in Advanced Ovarian, Tubal and Peritoneal Cancer. A 7-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.晚期卵巢癌、输卵管癌和腹膜癌的膈肌手术。卵巢癌网络肿瘤库的7年回顾性分析。
Anticancer Res. 2016 Sep;36(9):4707-13. doi: 10.21873/anticanres.11025.
10
Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer.在卵巢癌初次细胞减灭术中行膈肌腹膜切开术或切除术时行胸腔引流管放置的患者的术后结果。
Gynecol Oncol. 2014 Feb;132(2):299-302. doi: 10.1016/j.ygyno.2013.11.026. Epub 2013 Dec 1.

本文引用的文献

1
Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcome.融合影像引导下经皮射频消融治疗伴有人工腹水或胸腔积液的肝细胞癌: 可行性率和中期结果。
Int J Hyperthermia. 2023;40(1):2213424. doi: 10.1080/02656736.2023.2213424.
2
Comparison of the Contracted Accordion, Expanded Accordion, and Clavien-Dindo complication grading scales after ovarian cancer cytoreduction.卵巢癌细胞减灭术后缩拢式与扩张式牵开器及 Clavien-Dindo 并发症分级系统的比较。
Int J Gynecol Cancer. 2023 May 1;33(5):727-733. doi: 10.1136/ijgc-2022-003962.
3
FIGO staging in ovarian carcinoma and histological subtypes.
卵巢癌的国际妇产科联盟(FIGO)分期及组织学亚型
J Gynecol Oncol. 2020 Jul;31(4):e70. doi: 10.3802/jgo.2020.31.e70.
4
Tozzi classification of diaphragmatic surgery in patients with stage IIIC-IV ovarian cancer based on surgical findings and complexity.基于手术发现和复杂性的 IIIC-IV 期卵巢癌患者膈肌手术的 Tozzi 分类。
J Gynecol Oncol. 2020 Mar;31(2):e14. doi: 10.3802/jgo.2020.31.e14. Epub 2019 Sep 2.
5
Epithelial ovarian cancer.上皮性卵巢癌。
Lancet. 2019 Mar 23;393(10177):1240-1253. doi: 10.1016/S0140-6736(18)32552-2.
6
Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma.晚期卵巢癌、输卵管癌和腹膜癌初次肿瘤细胞减灭术中的膈肌手术及相关并发症
BMC Cancer. 2017 May 5;17(1):317. doi: 10.1186/s12885-017-3311-8.
7
Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?晚期IIIC期卵巢癌、输卵管癌和腹膜癌的最佳初始治疗:在初次肿瘤细胞减灭术中进行完全肉眼切除或新辅助化疗是仅有的选择吗?
Gynecol Oncol. 2017 Apr;145(1):15-20. doi: 10.1016/j.ygyno.2017.02.023. Epub 2017 Feb 21.
8
Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible.最大限度地减灭肿瘤细胞可改善卵巢癌患者的生存,即使完全肉眼可见的肿瘤切除无法实现。
Gynecol Oncol. 2017 Apr;145(1):21-26. doi: 10.1016/j.ygyno.2017.01.029. Epub 2017 Jan 31.
9
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.新诊断晚期卵巢癌的新辅助化疗:妇科肿瘤学会和美国临床肿瘤学会临床实践指南
Gynecol Oncol. 2016 Oct;143(1):3-15. doi: 10.1016/j.ygyno.2016.05.022. Epub 2016 Aug 8.
10
Surgical Techniques for Diaphragmatic Resection During Cytoreduction in Advanced or Recurrent Ovarian Carcinoma: A Systematic Review and Meta-analysis.晚期或复发性卵巢癌肿瘤细胞减灭术中膈肌切除术的手术技术:一项系统评价和Meta分析
Int J Gynecol Cancer. 2016 Feb;26(2):371-80. doi: 10.1097/IGC.0000000000000597.